High body temperature raised resistance to pathogenic viral infections: Study

Tokyo: Increased body temperature suppresses virus replication and excessive inflammatory responses, finds a study that showed the missing link between body temperature and infection resistance.

The study by researchers at The University of Tokyo in Japan showed that the high-body-temperature-dependent activation of gut microbiota boosts the serum and intestinal levels of bile acids.

 

This suppresses virus replication and inflammatory responses that follow influenza and SARS-CoV-2 infections.

 

Clinical evidence suggests that elderly individuals are at a higher risk of contracting viral infections.

 

Quite notably, the older people also have lower mean body temperatures.

 

However, the effects of increased body temperature on fighting viral infections remain largely unexplored.

 

In the study, published in the journal Nature Communications, the team bridged the gap by linking higher body temperature with an increased infection-fighting capability of the gut microorganisms or “microbiota”.

 

The team used mice which were heat- or cold-exposed at 4 degrees Celsius, 22 degrees Celsius, or 36 degrees Celsius a week before influenza virus infection.

 

After the viral infection was induced, the cold-exposed mice mostly died due to severe hypothermia, whereas the heat-exposed mice were highly resistant to the infection even at increasing doses of the virus.

 

“High-heat-exposed mice raise their basal body temperature above 38 degrees Celsius, allowing them to produce more bile acids in a gut microbiota-dependent manner,” said Takeshi Ichinohe from the Division of Viral Infection, The University of Tokyo.

 

The team speculated that signalling of deoxycholic acid (DCA) from the gut microbiota and its plasma membrane-bound receptor “Takeda G-protein-coupled receptor 5” (TGR5) increased host resistance to influenza virus infection by suppressing virus replication and neutrophil-dependent tissue damage.

 

While working on these experiments, the team noticed that mice infected with the influenza virus showed decreased body temperatures nearly four days after the onset of the infection, and they snuggled together to stay warm.

 

The team noticed similar results after switching the influenza virus with SARS-CoV-2 and the study results were also validated using a Syrian hamster model.

 

Their experiments revealed that body temperature over 38 degrees Celsius could increase host resistance to influenza virus and SARS-CoV-2 infections.

 

Moreover, they also found that such increase in body temperature catalyzed key gut microbial reactions, which in turn, led to the production of secondary bile acids.

 

These acids can modulate immune responses and safeguard the host against viral infections.

 

“The DCA and its nuclear farnesoid X receptor (FXR) agonist protect Syrian hamsters from lethal SARS-CoV-2 infection. Moreover, certain bile acids are reduced in the plasma of Covid-19 patients who develop moderate I/II disease compared with the minor severity of illness group,” Ichinohe said.

 

The team then performed extensive analysis to gain insight into the precise mechanisms underlying the gut-metabolite-mediated host resistance to viral infections in heat-exposed rodents.

 

Besides, they also established the role of secondary bile acids and bile acid receptors in mitigating viral infections.

 

–IANS